Quantitative analyses of all influenza type a viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays

Journal of Visualized Experiments

Volumn , Issue 50, 2011, Pages

  Gravel, Caroline ^a   Li, Changgui ^b   Wang, Junzhi ^b   Hashem, Anwar M ^a,c   Jaentschke, Bozena ^a   van Domselaar, Gary ^d   He, Runtao ^d   Li, Xuguang ^a,c  

^a HEALTH CANADA   (Canada)

^b National Institute for the Control of Pharmaceutical and Biological Products   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Hemagglutinin; Immunology; Influenza; Issue 50; Neuraminidase; Quantification; Universal antibody; Virology

Indexed keywords

EID: 80355149121     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2784     Document Type: Article

References (12)

1. Webster, R.G., Bean, W.J. Genetics of influenza virus. Annu Rev Genet. 12, 415-431 (1978).
2. Skehel, J.J., Wiley, D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 69, 531-569 (2000).
3. Wood, J.M. et al. The influence of the host cell on standardisation of influenza vaccine potency. Dev Biol Stand. 98, 183-188 (1999).
4. Sylte, M.J., Suarez, D.L. Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol. 333, 227-241 (2009).
5. Bright, R.A., Neuzil, K.M., Pervikov, Y., Palkonyay, L. WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 12, 2008. Vaccine. 27, 6366-6369 (2009).
6. Chun, S. et al. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine. 26, 6068-6076 (2008).
7. Gravel, C. et al. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences. Vaccine. 28, 5774-5784 (2010).
8. Li, C. et al. A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide. Nat Protoc. 5, 14-19 (2010).
9. Harvey, R., Wheeler, J.X., Wallis, C.L., Robertson, J.S., Engelhardt, O.G. Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). Vaccine. 26, 6550-6554 (2008).
10. Li, C. et al. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China. Biologicals. 38, 284-289 (2010).
11. Johansson, B.E., Pokorny, B.A., Tiso, V.A. Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition. Vaccine. 20, 1670-1674 (2002).
12. Hashem, A. et al. Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus. Biochem Biophys Res Comm [Epub ahead of print] (2010).